Clinical ink Announces Strategic Investment from Ardan Equity and GI Partners to Accelerate Next Phase of Growth
Summary
Clinical ink announced new strategic investments from Ardan Equity and GI Partners to support its next phase of growth. The company provides eClinical technologies such as eCOA and connected device solutions for pharmaceutical companies and CROs. Management said the capital and partner support will help Clinical ink expand globally, strengthen its platform, and pursue opportunities across clinical research and care. The company also highlighted prior growth in revenue, customer relationships, and product launches, including GlucoseReady, SPUR, and Kaitality.
Funding
Amount
-
Total raised
Date
October 19, 2026
Announcement date
Investors
Centerview Partners, GI Partners
Lead investors
Company
clinicalink.com
Funded company
AskAI Classifications
Sectors
HealthTech
Clinical Software
General Healthcare software
Functions
No functions detected
Linked Companies
Clinical ink
$10M to $25M